Financial reports
ARS
2023 FY
Annual report to shareholders
13 Mar 24
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
6 Apr 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
Current reports
8-K
Inari Medical Reports Fourth Quarter 2023 Financial Results
28 Feb 24
8-K
Departure of Directors or Certain Officers
23 Feb 24
8-K/A
Limflow Consolidated Financial Statements
31 Jan 24
8-K
Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance
9 Jan 24
8-K
Inari Medical Closes Acquisition of LimFlow
15 Nov 23
8-K
Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow
2 Nov 23
8-K
Inari Medical Reports Third Quarter 2023 Financial Results
1 Nov 23
8-K
Departure of Directors or Certain Officers
22 Sep 23
8-K
Inari Medical Reports Second Quarter 2023 Financial Results
2 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
19 May 23
Registration and prospectus
S-8
Registration of securities for employees
28 Feb 24
S-8
Registration of securities for employees
27 Feb 23
424B5
Prospectus supplement for primary offering
11 Mar 22
424B5
Prospectus supplement for primary offering
10 Mar 22
S-8
Registration of securities for employees
23 Feb 22
S-3ASR
Automatic shelf registration
23 Dec 21
S-8
Registration of securities for employees
11 Mar 21
S-8
Registration of securities for employees
27 May 20
424B4
Prospectus supplement with pricing info
26 May 20
S-1MEF
Registration of additional securities for an S-1
21 May 20
Proxies
DEFA14A
Additional proxy soliciting materials
13 Mar 24
DEF 14A
Definitive proxy
13 Mar 24
DEFA14A
Additional proxy soliciting materials
6 Apr 23
DEF 14A
Definitive proxy
6 Apr 23
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEF 14A
Definitive proxy
14 Apr 22
DEFA14A
Additional proxy soliciting materials
24 May 21
DEFA14A
Additional proxy soliciting materials
16 Apr 21
DEF 14A
Definitive proxy
16 Apr 21
Other
SD
Conflict minerals disclosure
31 May 23
EFFECT
Notice of effectiveness
22 May 20
CERT
Certification of approval for exchange listing
21 May 20
CORRESP
Correspondence with SEC
19 May 20
CORRESP
Correspondence with SEC
19 May 20
CORRESP
Correspondence with SEC
18 May 20
UPLOAD
Letter from SEC
12 May 20
CORRESP
Correspondence with SEC
4 Mar 20
UPLOAD
Letter from SEC
14 Jan 20
Ownership
4
William Hoffman
18 Apr 24
4
Mitch C. Hill,
16 Apr 24
4
Andrew Hykes
3 Apr 24
4
Mitch C. Hill,
3 Apr 24
4
William Hoffman
3 Apr 24
4
Thomas Tu
3 Apr 24
SC 13G
MILLENNIUM MANAGEMENT LLC
3 Apr 24
4
William Hoffman
20 Mar 24
144
Notice of proposed sale of securities
18 Mar 24
144
Notice of proposed sale of securities
15 Mar 24